Skip to content

Camber launches new IBS medication

This medication serves the needs of patients managing functional bowel disorders and IBS.

Table of Contents

Piscataway, NJ – Camber Pharmaceuticals has announced the launch of Dicyclomine Hydrochloride Capsules, USP, a new addition to its portfolio of medications. This product is designed to address the needs of patients managing functional bowel disorders and irritable bowel syndrome (IBS).

Dicyclomine Hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent specifically formulated to alleviate abdominal pain and discomfort associated with IBS by reducing muscle spasms in the gastrointestinal tract.

The capsules are available in a 10 mg strength and come in packaging options of 100-count and 1000-count bottles, offering flexibility for patients and healthcare providers alike.

For more details, including prescription information, visit www.camberpharma.com/dicyclominecapsules

Comments

Latest